The short answer
A harmful ropinirole–synephrine interaction has not been demonstrated. Evidence mainly concerns p-synephrine in bitter-orange preparations and is mixed. Review the exact supplement, caffeine content and any dizziness or palpitations with your prescriber before use.
What this answer covers
Generic synephrine with immediate-release oral ropinirole. Human studies cited here used specified p-synephrine/bitter-orange products; they do not authenticate every product labeled synephrine or establish the effects of different stimulants.
- Supplement or preparation
- Synephrine
- Medication ingredient
- ropinirole
A possible concern is not a proven interaction
Ropinirole can affect blood-pressure control on standing. Bitter-orange products have prompted cardiovascular concerns, but many reports involved mixtures and do not identify which ingredient was responsible. There is no measured ropinirole–synephrine risk estimate in the sources checked.
Some human studies found no stimulant effect
One small healthy-volunteer study found no significant heart-rate or systolic-pressure change with a specified p-synephrine extract. Another resting study found that higher-caffeine regimens raised systolic pressure while adding p-synephrine did not augment that response. These results limit a blanket warning that synephrine always stimulates the heart.
The tested conditions may not match yours
Those studies were short and did not include ropinirole users or assess the combination during standing. They cannot rule out individual symptoms or establish long-term safety. Check whether the product also contains caffeine or other stimulants; results for one formulation cannot identify the contents or effect of another.
There is no established timing workaround
No reliable dose-separation interval has been shown to make this combination safe. If you have fainting, troublesome dizziness or palpitations, obtain a clinical assessment rather than adding a stimulant to counter symptoms. Keep ropinirole changes coordinated with its prescriber.
Evidence and practical considerations
Side effects & toxicity
A harmful ropinirole–synephrine interaction has not been demonstrated. Evidence mainly concerns p-synephrine in bitter-orange preparations and is mixed. Review the exact supplement, caffeine content and any dizziness or palpitations with your prescriber before use.
- Exact scope
- Generic synephrine with immediate-release oral ropinirole. Human studies cited here used specified p-synephrine/bitter-orange products; they do not authenticate every product labeled synephrine or establish the effects of different stimulants. with Immediate-release oral ropinirole; hydrochloride tablets expressed as free-base equivalent in the original label.
- Medication form and route
- oral
What remains uncertain
- No quantified exact-pair risk or universal safe dose is established. Product effects and studies in different populations cannot establish the outcome during ropinirole co-use.
Factors that may matter: Exact product composition; Underlying indication and blood-pressure symptoms; Other medicines and planned changes.
Read the supporting source summaries
Source 1: Current U.S. regulatory product labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults using immediate-release oral ropinirole tablets for Parkinson disease or restless legs syndrome.
Label warns about sudden sleep episodes, orthostatic hypotension, hallucinations and compulsive behaviors. With prescribed L-dopa, dyskinesia was reported more often with ropinirole than placebo (34% versus 13%) in advanced-Parkinson trials.
How this applies: Exact medication evidence and an explicit hydrochloride/free-base bridge from section 11. Supports specified risks and prescriber supervision; not proof of an untested supplement interaction.
Those trial rates are not Mucuna, yohimbe or synephrine co-use rates. Immediate-release label findings do not establish every formulation or supplement dose.
Source 2: U.S. federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: People using bitter-orange supplements; many reported events involve mixtures.
Cardiovascular study findings are inconclusive. Serious events have been reported with multi-ingredient products, so the responsible component is uncertain.
How this applies: Supports product-specific assessment and uncertainty without attributing every stimulant event to synephrine.
Bitter-orange mixture reports do not isolate p-synephrine or establish ropinirole co-use risk; a generic synephrine name does not specify the tested preparation.
Source 3: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Eighteen healthy adults in a double-blind placebo-controlled crossover.
No significant ECG, heart-rate or systolic-pressure changes; a small diastolic reduction at one timepoint. No adverse effects reported.
How this applies: A null result for one preparation does not prove safety for the exact pair or every synephrine product.
Small acute healthy-volunteer study; no ropinirole or patient autonomic dysfunction. Background caffeine intake varied.
Source 4: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Sixteen participants in a randomized double-blind resting comparison.
Higher-caffeine regimens raised systolic pressure. Adding p-synephrine did not augment the observed systolic or heart-rate response; p-synephrine alone lowered diastolic pressure in this setting.
How this applies: Separates mixture ingredients and preserves contrary results; not proof that ropinirole and synephrine offset one another.
Short study at rest, no ropinirole and no established response during standing, exercise or long-term use.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft. Exact preparation limits and contrary findings documented; clinical review not recorded. | |
| Research summary published |
Article revision: b538c2269451be4d
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.